0
Sonoma Pharmaceuticals, Inc. Banner Image

Sonoma Pharmaceuticals, Inc. has reached its limit for free report views

Work for Sonoma Pharmaceuticals, Inc.? Upgrade Your Profile and unlock all your annual reports.

Sonoma Pharmaceuticals, Inc.

  • Ticker SNOA
    Exchange NASDAQ More
  • Industry Drug Manufacturers - Major More
  • Sector Healthcare More
Sonoma Pharmaceuticals, Inc. Logo Image
  • 11-50 Employees
  • Based in Petaluma, California
Sonoma Pharmaceuticals is a global healthcare leader for developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, animal health care, eye care, nasal care, oral care and dermatological conditions. The company’s products reduce infections, itch, pain, scarring and harmful inflammatory responses in a safe and effective mannerMore. In-vitro and clinical studies of hypochlorous acid (HOCl) show it to have impressive antipruritic, antimicrobial, antiviral and anti-inflammatory properties. Sonoma’s stabilized HOCl immediately relieves itch and pain, kills pathogens and breaks down biofilm, does not sting or irritate skin and oxygenates the cells in the area treated assisting the body in its natural healing process. The company’s products are sold either directly or via partners in 53 countries worldwide and the company actively seeks new distribution partners. The company’s principal office is in Woodstock, Georgia, with manufacturing operations in Latin America. European marketing and sales are headquartered in Roermond, Netherlands.
Sonoma Pharmaceuticals, Inc.

Most Recent Annual Report

Sonoma Pharmaceuticals, Inc. MOST RECENT 2020 Annual Report and Form 10K

Report Locked. Sonoma Pharmaceuticals, Inc. has reached its limit for free report views.

Older/Archived Annual Reports